Skip to main content

In Utero Delivery of Oligodeoxynucleotides for Gene Correction

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1114))

Abstract

Gene correction is attractive for single gene mutation disorders, such as Duchenne muscular dystrophy (DMD). The mdx mouse model of DMD is dystrophin deficient due to a premature chain-terminating point mutation in exon 23 of the dystrophin gene. Gene editing of genomic DNA using single-stranded oligodeoxynucleotides (ssODNs) offers the potential to change the DNA sequence to alter mRNA and protein expression in defined ways. When applied to fetal skeletal muscle of mdx mice in utero, this technology leads to restoration of dystrophin protein expression, thus providing a valid gene-based therapeutic application at the earliest developmental stage. Here, we describe detailed methods for gene editing using muscle delivery of ssODNs to the fetal mdx mouse in utero at embryonic day 16 and to test correction of dystrophin deficiency at different ages after birth.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Engel AG, Ozawa E (2004) Dystrophinopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology, 3rd edn. McGraw-Hill, New York, pp 961–1025

    Google Scholar 

  2. Zellweger H, Antonik A (1975) Newborn screening for Duchenne muscular dystrophy. Pediatrics 55:30–34

    CAS  PubMed  Google Scholar 

  3. Koppanati BM, Li J, Reay DP, Wang B, Daood M, Zheng H, Xiao X, Watchko JF, Clemens PR (2010) Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene. Gene Ther 17:1355–1362

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Reay DP, Bilbao R, Koppanati BM, Cai L, O’Day TL, Jiang Z, Zheng H, Watchko JF, Clemens PR (2008) Full-length dystrophin gene transfer to the mdx mouse in utero. Gene Ther 15:531–536

    Article  CAS  PubMed  Google Scholar 

  5. Bertoni C (2008) Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides. Front Biosci 13:517–527

    Article  CAS  PubMed  Google Scholar 

  6. Bartlett RJ, Stockinger S, Denis MM, Bartlett WT, Inverardi L, Le TT, Man N, Morris GE, Bogan DJ, Metcalf-Bogan J, Kornegay JN (2000) In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat Biotechnol 18:615–622

    Article  CAS  PubMed  Google Scholar 

  7. Bertoni C, Rando TA (2002) Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum Gene Ther 13:707–718

    Article  CAS  PubMed  Google Scholar 

  8. Bertoni C, Lau C, Rando TA (2003) Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping. Hum Mol Genet 12:1087–1099

    Article  CAS  PubMed  Google Scholar 

  9. Bertoni C, Morris GE, Rando TA (2005) Strand bias in oligonucleotide-mediated dystrophin gene editing. Hum Mol Genet 14:221–233

    Article  CAS  PubMed  Google Scholar 

  10. Bertoni C, Rustagi A, Rando TA (2009) Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotides. Nucleic Acids Res 37:7468–7482

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Kayali R, Bury F, Ballard M, Bertoni C (2010) Site-directed gene repair of the dystrophin gene mediated by PNA-ssODNs. Hum Mol Genet 19:3266–3281

    Article  CAS  PubMed  Google Scholar 

  12. Rando TA, Disatnik MH, Zhou LZ (2000) Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc Natl Acad Sci U S A 97:5363–5368

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by NIAMS grant R01-AR050565 (PRC). We appreciate the input of Thomas A. Rando, M.D., Ph.D., Stanford University, and Daniel Reay, University of Pittsburgh, toward the development of these protocols. The authors take full responsibility for the contents of this chapter, which do not represent the views of the Department of Veterans Affairs or the United States Government.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Cai, L., Koppanati, B.M., Bertoni, C., Clemens, P.R. (2014). In Utero Delivery of Oligodeoxynucleotides for Gene Correction. In: Storici, F. (eds) Gene Correction. Methods in Molecular Biology, vol 1114. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-761-7_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-761-7_26

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-760-0

  • Online ISBN: 978-1-62703-761-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics